Gene: KLHL17
Official Full Name: kelch like family member 17provided by HGNC
Gene Summary: The protein encoded by this gene is expressed in neurons of most regions of the brain. It contains an N-terminal BTB domain, which mediates dimerization of the protein, and a C-terminal Kelch domain, which mediates binding to F-actin. This protein may play a key role in the regulation of actin-based neuronal function. [provided by RefSeq, Aug 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16671 | KLHL17 Knockout cell line (HeLa) | Human | KLHL17 | 1:3~1:6 | Negative | Online Inquiry |
KO16672 | KLHL17 Knockout cell line (HCT 116) | Human | KLHL17 | 1:2~1:4 | Negative | Online Inquiry |
KO16673 | KLHL17 Knockout cell line (HEK293) | Human | KLHL17 | 1:3~1:6 | Negative | Online Inquiry |
KO16674 | KLHL17 Knockout cell line (A549) | Human | KLHL17 | 1:3~1:4 | Negative | Online Inquiry |
KLHL17 Gene Knockout Cell Lines are specialized cellular models that have been genetically modified to induce a loss-of-function mutation in the KLHL17 gene. This gene encodes a member of the Kelch-like protein family, which is known to participate in various cellular processes, including protein ubiquitination and signal transduction pathways. By creating a knockout model, researchers can precisely dissect the functional role of KLHL17 in cellular processes, immune responses, and disease pathology, allowing for a deeper understanding of its contribution to both normal physiology and pathological conditions.
These cell lines operate through the precise editing of genomic sequences using CRISPR/Cas9 technology, which facilitates targeted gene disruption with high accuracy and efficiency. The resulting knockout cells provide a platform for investigating gene function, drug response, and molecular interactions at an unprecedented level of detail, thus serving as an invaluable tool in both academic and clinical research settings.
The scientific importance of KLHL17 Gene Knockout Cell Lines is underscored by their potential applications in studies of cancer, neurodegenerative diseases, and immune system disorders. Understanding how the loss of KLHL17 affects various signaling networks can lead to novel therapeutic strategies and biomarker discoveries.
Compared to traditional knockdown methodologies such as siRNA or shRNA, knockout cell lines offer permanence in gene inactivation, enabling long-term studies without the caveats of transient expression systems. This stability enhances reproducibility and accuracy in experimental outcomes, making it a superior choice for rigorous scientific investigation.
For researchers and clinicians keen to delve into the mechanistic roles of KLHL17, these knockout cell lines provide a foundational resource that can lead to pivotal insights and advancements in therapeutic development. Our company specializes in delivering high-quality genetic tools to the research community, ensuring unparalleled support and expertise in gene editing technologies, making us a trusted partner for innovative scientific explorations.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.